By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.




CEO: John F. Milligan, PhD

Chief Scientific Officer: Norbert W. Bischofberger, PhD

CFO: Robin L. Washington

COO: Kevin Young


Please click here for clinical trial information.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD

Company News
Gilead (GILD) Announces Second Quarter 2017 Financial Results 7/27/2017 7:51:14 AM
Gilead (GILD) Announces Third Quarter 2017 Dividend 7/27/2017 7:48:54 AM
Why Gilead (GILD) Should Consider Breaking The Company Up Into Two 7/27/2017 6:52:55 AM
Gilead (GILD) Boosted By New Late-Stage HIV Data 7/24/2017 7:49:50 AM
FDA Green Lights Gilead (GILD)'s Vosevi, With a Black Box Warning Attached 7/19/2017 5:45:29 AM
Why Incyte (INCY) Is Still A Good Backup Plan For Gilead (GILD) 7/14/2017 6:33:46 AM
Gilead (GILD) To Release Second Quarter 2017 Financial Results On Wednesday, July 26, 2017 7/13/2017 6:52:54 AM
EMA Validates Gilead (GILD)’s Marketing Application For Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide For Treatment Of HIV 7/13/2017 6:34:39 AM
Spring Bank Pharmaceuticals, Inc. Announces Collaboration With Gilead (GILD) For Hepatitis B (HBV) Phase II Study Exploring Combination Treatment Of SB 9200 And Vemlidy 7/10/2017 10:20:23 AM
Gilead (GILD)'s History Of Acquisitions Could Predict The Type Of Deal The Biotech Is Looking For 7/10/2017 6:15:45 AM